These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6143022)

  • 21. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff.
    Crosnier J; Jungers P; Couroucé AM; Laplanche A; Benhamou E; Degos F; Lacour B; Prunet P; Cerisier Y; Guesry P
    Lancet; 1981 Feb; 1(8218):455-9. PubMed ID: 6110088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An intradermal vaccine protocol against hepatitis B in a haemodialysis population.
    Vincent L; John GT; Abraham P; Jacob CK
    Natl Med J India; 1998; 11(1):48. PubMed ID: 9557522
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenicity and efficacy of anti-hepatitis B vaccines in hemodialysis patients.
    Dentico P; Volpe A; Buongiorno R; Maracchione N; Carbone M; Manno C; Proscia F
    Nephron; 1992; 61(3):324-5. PubMed ID: 1386904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
    Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis: the dialysis mode and immunological response to hepatitis B virus vaccine in dialysis population.
    Fabrizi F; Dixit V; Bunnapradist S; Martin P
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1105-12. PubMed ID: 16611270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of heat-inactivated hepatitis B vaccine (CLB) in low risk human volunteers and in patients treated with chronic haemodialysis in the Netherlands.
    Reerink-Brongers EE; Lelie PN; Reesink HW; Dees PJ; Brummelhuis HG; van Aken WG
    Dev Biol Stand; 1983; 54():197-203. PubMed ID: 6228459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zinc supplementation and hepatitis B vaccination in chronic haemodialysis patients: a multicentre study.
    Brodersen HP; Holtkamp W; Larbig D; Beckers B; Thiery J; Lautenschläger J; Probst HJ; Ropertz S; Yavari A
    Nephrol Dial Transplant; 1995; 10(9):1780. PubMed ID: 8559509
    [No Abstract]   [Full Text] [Related]  

  • 29. Newly licensed hepatitis B vaccine. Known safety and unknown risks.
    Gerety RJ; Tabor E
    JAMA; 1983 Feb; 249(6):745-6. PubMed ID: 6337271
    [No Abstract]   [Full Text] [Related]  

  • 30. Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2011 Oct; 18(10):730-7. PubMed ID: 20819147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral hepatitis: standardization in immunoprophylaxis of infections by hepatitis viruses. Proceedings of a symposium, Athens, Greece, November 15-18, 1982.
    Dev Biol Stand; 1983; 54():1-585. PubMed ID: 6228450
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis B vaccine in patients on haemodialysis.
    Jaiswal SB; Salgia PB; Sepaha AG; Chitnis DS
    Lancet; 1995 Jul; 346(8970):317-8. PubMed ID: 7630276
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of the accelerated hepatitis B vaccination schedule used in haemodialysis patients post-exposure to virus: a single-centre experience.
    Eardley KS; Jones HE; Osman H; Smith SA
    Nephrol Dial Transplant; 2002 Nov; 17(11):1982-7. PubMed ID: 12401857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
    Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The task of epidemiology in designing strategies for the use of hepatitis B virus vaccine.
    Kane MA
    Public Health Rep; 1984; 99(3):264-6. PubMed ID: 6234611
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of immunomodulators (thymopentine) in hepatitis B vaccine in elderly patients undergoing chronic hemodialysis.
    Melappioni M; Baldassari M; Baldini S; Radicioni R; Panichi N
    Nephron; 1992; 61(3):358-9. PubMed ID: 1386910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of intradermal injection of recombinant hepatitis B vaccine in dialysis patients.
    Poux JM; Ranger S; Lagarde C; Benevent D; Denis F; Leroux-Robert C
    Nephrol Dial Transplant; 1994; 9(8):1213-4. PubMed ID: 7800237
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study.
    Misurac JM; VanDeVoorde RG; Kallash M; Iorember FM; Luckritz KE; Rheault MN; Jetton JG; Turman MA; Kapur G; Twombley KE; Hashmat S; Weaver DJ; Leiser JD; Nailescu C
    Clin J Am Soc Nephrol; 2017 May; 12(5):772-778. PubMed ID: 28270432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B vaccine.
    Krugman S
    Pediatr Infect Dis; 1982; 1(4):217-8. PubMed ID: 6217456
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vaccination against hepatitis B virus. Value of intradermal administration in dialysed patients non responsive to intramuscular approach].
    Poux JM; Ranger-Rogez S; Lagarde C; Benevent D; Denis F; Leroux-Robert C
    Presse Med; 1995 May 6-13; 24(17):803-6. PubMed ID: 7630869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.